Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52 percent Y-o-Y
Total Income in H1FY27 up 18.39% Y-o-Y to Rs. 402.43 crore; EBITDA in H1FY27 up 18.37% Y-o-Y to Rs. 84.92 crore Ahmedabad (Gujarat) [India], October 29: Lincoln Pharmaceuticals Limited (BSE: 531633, NSE: LINCOLN), one of India’s leading healthcare companies has reported a consolidated net profit of Rs. 57.50 crore for the H1FY27 ended September 2026 as […]
Continue Reading